Phase II Trial of AZD6738 Alone and in Combination With Olaparib in Patients With Selected Solid Tumor Malignancies
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2019
At a glance
- Drugs AZD 6738 (Primary) ; Olaparib (Primary)
- Indications Adenocarcinoma; Carcinoma; Pancreatic cancer; Renal cell carcinoma; Solid tumours; Urogenital cancer
- Focus Therapeutic Use
- 21 Dec 2018 Status changed from not yet recruiting to recruiting.
- 19 Oct 2018 Planned initiation date changed from 1 Oct 2018 to 1 Dec 2018.
- 28 Sep 2018 New trial record